China Biologic Products Holdings, Inc. (NASDAQ:CBPO) management will conduct a conference call for 25th November 2020 at 7:30 AM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.chinabiologic.com
To participate in the conference call, local and international callers can dial 1 888 346 8982 or 1 412 902 4272 Toll Number
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the Peoples Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia.